Intradermal angiotensin II administration attenuates the local cutaneous vasodilator heating response

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 295, Issue 1, 2008, Pages

  Stewart, Julian M ^a   Taneja, Indu ^a   Raghunath, Neeraj ^a   Clarke, Debbie ^a   Medow, Marvin S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Conductance; Lasers; Skin

Indexed keywords

ANGIOTENSIN II; ASCORBIC ACID; LOSARTAN; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; 1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; NITRIC OXIDE; PYRIDINE DERIVATIVE; VASOCONSTRICTOR AGENT;

ADULT; ARTICLE; CATHETER; CONTROLLED STUDY; FEMALE; HEART HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; LASER DOPPLER FLOWMETRY; MALE; MICRODIALYSIS; PRIORITY JOURNAL; SKIN BLOOD FLOW; SKIN CONDUCTANCE; VASODILATATION; BLOOD FLOW; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HEAT; INFUSION; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; RANDOMIZED CONTROLLED TRIAL; SKIN; SKIN TEMPERATURE; VASCULARIZATION;

ADMINISTRATION, CUTANEOUS; ADULT; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIOXIDANTS; ASCORBIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; HEAT; HUMANS; IMIDAZOLES; INFUSIONS, PARENTERAL; LOSARTAN; MALE; MICRODIALYSIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 2; REGIONAL BLOOD FLOW; SKIN; SKIN TEMPERATURE; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 49849088967     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00126.2008     Document Type: Article

References (33)

1. Agoudemos MM, Greene AS. Localization of the renin-angiotensin system components to the skeletal muscle microcirculation. Microcirculation 12: 627-636, 2005.
2. Anderson C, Andersson T, Wardell K. Changes in skin circulation after insertion of a microdialysis probe visualized by laser Doppler perfusion imaging. J Invest Dermatol 102: 807-811, 1994.
3. Bailey SR, Mitra S, Flavahan S, Flavahan NA. Reactive oxygen species from smooth muscle mitochondria initiate cold-induced constriction of cutaneous arteries. Am J Physiol Heart Circ Physiol 289: H243-H250, 2005.
4. G-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res 72: 387-395, 1993.
5. Chang HY, Chen CW, Hsiue TR. Comparative effects of L-NOARG and L-NAME on basal blood flow and ACh-induced vasodilatation in rat diaphragmatic microcirculation. Br J Pharmacol 120: 326-332, 1997.
6. Clemson B, Gaul L, Gubin SS, Campsey DM, McConville J, Nussberger J, Zelis R. Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm. J Clin Invest 93: 684-691, 1994.
7. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: E1-E9, 2000.
8. Ferrario CM, Trask AJ, Jessup JA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 289: H2281-H2290, 2005.
9. Franco M, Martinez F, Quiroz Y, Galicia O, Bautista R, Johnson RJ, Rodriguez-Iturbe B. Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 293: R251-R256, 2007.
10. Frossard M, Joukhadar C, Steffen G, Schmid R, Eichler HG, Muller M. Paracrine effects of angiotensin-converting-enzyme- and angiotensin-II-receptor-inhibition on transcapillary glucose transport in humans. Life Sci 66: L147-L154, 2000.
11. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 91: 21-27, 2000.
12. Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4: 899-914, 2002.
13. Harrison DG, Cai H, Landmesser U, Griendling KK. Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 4: 51-61, 2003.
14. Holowatz LA, Houghton BL, Wong BJ, Wilkins BW, Harding AW, Kenney WL, Minson CT. Nitric oxide and attenuated reflex cutaneous vasodilation in aged skin. Am J Physiol Heart Circ Physiol 284: H1662-H1667, 2003.
15. Holowatz LA, Kenney WL. Local ascorbate administration augments NO- and non-NO-dependent reflex cutaneous vasodilation in hypertensive humans. Am J Physiol Heart Circ Physiol 293: H1090-H1096, 2007.
16. Johnson JM, O'Leary DS, Taylor WF, Kosiba W. Effect of local warming on forearm reactive hyperaemia. Clin Physiol 6: 337-346, 1986.
17. Kellogg DL Jr, Liu Y, Kosiba IF, O'Donnell D. Role of nitric oxide in the vascular effects of local warming of the skin in humans. J Appl Physiol 86: 1185-1190, 1999.
18. Medow MS, Minson CT, Stewart JM. Decreased microvascular nitric oxide-dependent vasodilation in postural tachycardia syndrome. Circulation 112: 2611-2618, 2005.
19. Minson CT, Berry LT, Joyner MJ. Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol 91: 1619-1626, 2001.
20. Minson CT, Holowatz LA, Wong BJ, Kenney WL, Wilkins BW. Decreased nitric oxide- and axon reflex-mediated cutaneous vasodilation with age during local heating. J Appl Physiol 93: 1644-1649, 2002.
21. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424, 2007.
22. Santos RA, Brosnihan KB, Chappell MC, Pesquero J, Chernicky CL, Greene LJ, Ferrario CM. Converting enzyme activity and angiotensin metabolism in the dog brainstem. Hypertension 11: I153-I157, 1988.
23. Santos RA, Ferreira AJ, Simöes e Silva AC. Recent advances in the angiotensin-converting enzyme 2-ANG-(1-7)-Mas axis. Exp Physiol 93: 519-527, 2008.
24. Steckelings UM, Wollschlager T, Peters J, Henz BM, Hermes B, Artuc M. Human skin: source of and target organ for angiotensin II. Exp Dermatol 13: 148-154, 2004.
25. Stewart JM, Glover JL, Medow MS. Increased plasma angiotensin II in postural tachycardia syndrome (POTS) is related to reduced blood flow and blood volume. Clin Sci (Lond) 110: 255-263, 2006.
26. Stewart JM, Taneja I, Glover J, Medow MS. Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 294: H466-H473, 2008.
27. Stewart JM, Taneja I, Medow MS. Reduced body mass index is associated with increased angiotensin-II in young women with postural tachycardia syndrome. Clin Sci (Lond) 113: 449-457, 2007.
28. Stragier B, Hristova I, Sarre S, Ebinger G, Michotte Y. In vivo characterization of the angiotensin-(1-7)-induced dopamine and gamma-aminobutyric acid release in the striatum of the rat. Eur J Neurosci 22: 658-664, 2005.
29. Thompson-Torgerson CS, Holowatz LA, Flavahan NA, Kenney WL. Cold-induced cutaneous vasoconstriction is mediated by Rho kinase in vivo in human skin. Am J Physiol Heart Circ Physiol 292: H1700-H1705, 2007.
30. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52: 639-672, 2000.
31. Wei CC, Meng QC, Palmer R, Hageman GR, Durand J, Bradley WE, Farrell DM, Hankes GH, Oparil S, Dell'Italia LJ. Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo. Circulation 99: 2583-2589, 1999.
32. Wilkins BW, Martin EA, Roberts SK, Joyner MJ. Preserved reflex cutaneous vasodilation in cystic fibrosis does not include an enhanced nitric oxide-dependent mechanism. J Appl Physiol 102: 2301-2306, 2007.
33. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol 20: 1430-1442, 2000.